These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21115120)

  • 1. Selective impairment of CD4+CD25+Foxp3+ regulatory T cells by paclitaxel is explained by Bcl-2/Bax mediated apoptosis.
    Liu N; Zheng Y; Zhu Y; Xiong S; Chu Y
    Int Immunopharmacol; 2011 Feb; 11(2):212-9. PubMed ID: 21115120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.
    Cao Q; Wang L; Du F; Sheng H; Zhang Y; Wu J; Shen B; Shen T; Zhang J; Li D; Li N
    Cell Res; 2007 Jul; 17(7):627-37. PubMed ID: 17563757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
    Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+Foxp3+ regulatory T-cell impairment by paclitaxel is independent of toll-like receptor 4.
    Zhu Y; Liu N; Xiong SD; Zheng YJ; Chu YW
    Scand J Immunol; 2011 Apr; 73(4):301-8. PubMed ID: 21223350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.
    Qu Y; Zhang B; Zhao L; Liu G; Ma H; Rao E; Zeng C; Zhao Y
    Transpl Immunol; 2007 Apr; 17(3):153-61. PubMed ID: 17331841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
    Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
    Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting CD4+CD25+FoxP3+ regulatory T-cells for the augmentation of cancer immunotherapy.
    Schabowsky RH; Madireddi S; Sharma R; Yolcu ES; Shirwan H
    Curr Opin Investig Drugs; 2007 Dec; 8(12):1002-8. PubMed ID: 18058571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory T cells are necessary for implantation and maintenance of early pregnancy but not late pregnancy in allogeneic mice.
    Shima T; Sasaki Y; Itoh M; Nakashima A; Ishii N; Sugamura K; Saito S
    J Reprod Immunol; 2010 Jun; 85(2):121-9. PubMed ID: 20439117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma-ray resistance of regulatory CD4+CD25+Foxp3+ T cells in mice.
    Qu Y; Jin S; Zhang A; Zhang B; Shi X; Wang J; Zhao Y
    Radiat Res; 2010 Feb; 173(2):148-57. PubMed ID: 20095846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of CD4+CD25+Foxp3+ regulatory T cells in aged Balb/c mice.
    Zhao L; Sun L; Wang H; Ma H; Liu G; Zhao Y
    J Leukoc Biol; 2007 Jun; 81(6):1386-94. PubMed ID: 17369496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct responses of two hepatocellular carcinoma cell lines of a similar origin to immunotherapies targeting regulatory or effector T cells.
    Nagayama Y; Hase W; Motoyoshi Y; Saitoh O; Sogawa R; Nakao K
    Oncol Rep; 2007 May; 17(5):1269-73. PubMed ID: 17390075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective depletion of CD4+CD25+Foxp3+ regulatory T cells by low-dose cyclophosphamide is explained by reduced intracellular ATP levels.
    Zhao J; Cao Y; Lei Z; Yang Z; Zhang B; Huang B
    Cancer Res; 2010 Jun; 70(12):4850-8. PubMed ID: 20501849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysfunction of CD4+CD25high T regulatory cells in patients with recurrent aphthous stomatitis.
    Lewkowicz N; Lewkowicz P; Dzitko K; Kur B; Tarkowski M; Kurnatowska A; Tchórzewski H
    J Oral Pathol Med; 2008 Sep; 37(8):454-61. PubMed ID: 18318707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential impairment of regulatory T cells rather than effector T cells by paclitaxel-based chemotherapy.
    Zhang L; Dermawan K; Jin M; Liu R; Zheng H; Xu L; Zhang Y; Cai Y; Chu Y; Xiong S
    Clin Immunol; 2008 Nov; 129(2):219-29. PubMed ID: 18771959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice.
    Javeed A; Zhang B; Qu Y; Zhang A; Sun C; Zhang L; Liu J; Zeng C; Zhao Y
    Transpl Immunol; 2009 Mar; 20(4):253-60. PubMed ID: 19146957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
    Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
    Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impairment of regulatory capacity of CD4+CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves' disease.
    Mao C; Wang S; Xiao Y; Xu J; Jiang Q; Jin M; Jiang X; Guo H; Ning G; Zhang Y
    J Immunol; 2011 Apr; 186(8):4734-43. PubMed ID: 21398613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deacetylase inhibitor trichostatin A down-regulates Foxp3 expression and reduces CD4+CD25+ regulatory T cells.
    Liu Z; Zhang C; Sun J
    Biochem Biophys Res Commun; 2010 Sep; 400(3):409-12. PubMed ID: 20801101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease.
    Chen X; Zhou B; Li M; Deng Q; Wu X; Le X; Wu C; Larmonier N; Zhang W; Zhang H; Wang H; Katsanis E
    Clin Immunol; 2007 Apr; 123(1):50-9. PubMed ID: 17234458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.